Tags

Type your tag names separated by a space and hit enter

Optic canal size in idiopathic intracranial hypertension and asymmetric papilledema.
Clin Neurol Neurosurg. 2019 Sep; 184:105376.CN

Abstract

OBJECTIVE

Asymmetric papilledema (AP) is a rare condition in idiopathic intracranial hypertension (IIH). As the pathophysiology of papilledema developement in IIH remains unclear, the study of AP could clarify some etiologic aspects. We aimed to evaluate bony optic canal size in IIH patients with AP.

PATIENTS AND METHODS

All IIH patients based on modified Dandy criteria in our referral tertiary eye hospital underwent neuro-opthalmologic exams and grading of papilledema according to modified Frisén scale. Very asymmetric papilledema (VAP) defined as a ≥2 grade difference between the two eyes. Clinical features, cerebrospinal fluid opening pressure (CSF OP), best corrected visual acuity, Humphery visual field, and brain magnetic resonance imaging (MRI) and MR venography was performed for all patients. Spiral orbital computed tomography (CT) scan which is the choice method for details of bony structures with axial, coronal and sagittal planes was done in patients with VAP.

RESULT

59 patients with IIH were diagnosed that 18.6% of them (n = 11) had VAP. There was no IIH patient with strictly unilateral Papilledema. Presenting symptoms and CSF OP was not significantly different between patients with symmetric and asymmetric papilledema. In patients with VAP, bony optic canal size was not statistically significant different in axial, coronal and sagittal plane when comparing the eye with higher grade edema to the fellow eye.

CONCLUSION

Our study showed that bony optic canal size evaluated by orbital CT scan was not different in VAP in IIH patients. Finding the exact pathophysiology of AP need further studies.

Authors+Show Affiliations

Department of Radiology, Emam Khomeini Hospital, Urmia University of Medical Sciences, Urmia, Iran.Department of Radiology, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: kashanis@sina.tums.ac.ir.Department of Neuro-ophthalmology and Strabismus, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran; Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran; Department of Orbit and Oculoplastic Surgery, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.Department of Neuro-ophthalmology and Strabismus, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran; Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: yadegarisamira@yahoo.com.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

31176474

Citation

Farrokhi, Yasin, et al. "Optic Canal Size in Idiopathic Intracranial Hypertension and Asymmetric Papilledema." Clinical Neurology and Neurosurgery, vol. 184, 2019, p. 105376.
Farrokhi Y, Sharif Kashani S, Aghsaei Fard M, et al. Optic canal size in idiopathic intracranial hypertension and asymmetric papilledema. Clin Neurol Neurosurg. 2019;184:105376.
Farrokhi, Y., Sharif Kashani, S., Aghsaei Fard, M., Pakdel, F., & Yadegari, S. (2019). Optic canal size in idiopathic intracranial hypertension and asymmetric papilledema. Clinical Neurology and Neurosurgery, 184, 105376. https://doi.org/10.1016/j.clineuro.2019.105376
Farrokhi Y, et al. Optic Canal Size in Idiopathic Intracranial Hypertension and Asymmetric Papilledema. Clin Neurol Neurosurg. 2019;184:105376. PubMed PMID: 31176474.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Optic canal size in idiopathic intracranial hypertension and asymmetric papilledema. AU - Farrokhi,Yasin, AU - Sharif Kashani,Shervin, AU - Aghsaei Fard,Masoud, AU - Pakdel,Farzad, AU - Yadegari,Samira, Y1 - 2019/05/22/ PY - 2018/07/29/received PY - 2019/05/12/revised PY - 2019/05/21/accepted PY - 2019/6/10/pubmed PY - 2020/10/24/medline PY - 2019/6/10/entrez KW - Asymmetric papilledema KW - Idiopathic intracranial hypertension KW - Optic canal SP - 105376 EP - 105376 JF - Clinical neurology and neurosurgery JO - Clin Neurol Neurosurg VL - 184 N2 - OBJECTIVE: Asymmetric papilledema (AP) is a rare condition in idiopathic intracranial hypertension (IIH). As the pathophysiology of papilledema developement in IIH remains unclear, the study of AP could clarify some etiologic aspects. We aimed to evaluate bony optic canal size in IIH patients with AP. PATIENTS AND METHODS: All IIH patients based on modified Dandy criteria in our referral tertiary eye hospital underwent neuro-opthalmologic exams and grading of papilledema according to modified Frisén scale. Very asymmetric papilledema (VAP) defined as a ≥2 grade difference between the two eyes. Clinical features, cerebrospinal fluid opening pressure (CSF OP), best corrected visual acuity, Humphery visual field, and brain magnetic resonance imaging (MRI) and MR venography was performed for all patients. Spiral orbital computed tomography (CT) scan which is the choice method for details of bony structures with axial, coronal and sagittal planes was done in patients with VAP. RESULT: 59 patients with IIH were diagnosed that 18.6% of them (n = 11) had VAP. There was no IIH patient with strictly unilateral Papilledema. Presenting symptoms and CSF OP was not significantly different between patients with symmetric and asymmetric papilledema. In patients with VAP, bony optic canal size was not statistically significant different in axial, coronal and sagittal plane when comparing the eye with higher grade edema to the fellow eye. CONCLUSION: Our study showed that bony optic canal size evaluated by orbital CT scan was not different in VAP in IIH patients. Finding the exact pathophysiology of AP need further studies. SN - 1872-6968 UR - https://www.unboundmedicine.com/medline/citation/31176474/Optic_canal_size_in_idiopathic_intracranial_hypertension_and_asymmetric_papilledema_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0303-8467(19)30164-7 DB - PRIME DP - Unbound Medicine ER -